Ausgabe 15-16/2022 Multiple Sklerose
Inhalt (9 Artikel)
Multiple sclerosis at the crossroads of scientific evidence and clinical translation
- editorial
Johann Sellner
Retinal imaging with optical coherence tomography in multiple sclerosis: novel aspects
- Open Access
- main topic
Elisabeth Olbert, Walter Struhal
Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis—from diagnosis to prediction of disease activity
- Open Access
- main topic
Harald Hegen, Klaus Berek, Florian Deisenhammer
An overview of pivotal trials and real-world evidence for CD20-depleting therapy in multiple sclerosis
- main topic
Arkady Ovchinnikov, Oliver Findling
Real-world evidence for cladribine tablets in multiple sclerosis: further insights into efficacy and safety
- Open Access
- main topic
Tobias Moser, Tjalf Ziemssen, Johann Sellner
Natalizumab treatment during pregnancy in multiple sclerosis—clinical and bioethical aspects of an ongoing debate
- main topic
Klaus Berek, Claudia Paganini, Harald Hegen, Gabriel Bsteh, Astrid Grams, Michael Auer, Thomas Berger, Florian Deisenhammer, Franziska Di Pauli
Tumefactive demyelinating CNS lesion in a 60-year-old woman with familial Mediterranean fever
- Open Access
- main topic
Constanze Trostel, Kornelia Laichinger, Till-Karsten Hauser, Sebastian Saur, Markus Krumbholz, Jörg Henes, Ulf Ziemann, Markus C. Kowarik
Neuer Masterstudiengang: Multiple Sklerose Management
- Multiple Sklerose
- themenschwerpunkt
Isabel Voigt, Christine Stadelmann, Sven G. Meuth, Bernhard Schipp, Peter Flachenecker, Mathias Mäurer, Richard H. W. Funk, Franziska Ramisch, Joachim Niemeier, Tjalf Ziemssen
